Measurement of growth in children with renal insufficiency  by Potter, Donald E. et al.
Kidney international, Vol. 14 (1978), pp. 378—382
Measurement of growth in children with renal insufficiency
DONALD E. POTTER, MICHEL BROYER, CYRIL CHANTLER, ALAN GRUSKIN, MALCOLM A.
HOLLIDAY, ALEX ROCHE, KARL SCHARER, and DAVID THISSEN
Children's Renal Center, University of California at San Francisco, San Francisco, California; Hópital Necker Enfants
Malades, Paris, France; Guys Hospital, London Bridge, England; Child Health Associates, Inc., Philadelphia,
Pennsylvania; Children's Renal Center, University of California at San Francisco, San Francisco, California; The Fels
Research Institute, Yellow Springs, Ohio; Klinkum der Universität Heidelberg, Heidelberg, West Germany; and
University of Kansas, Lawrence, Kansas
The assessment of growth in children with kidney
disease includes measurements of stature, nutri-
tional status, skeletal maturity, and sexual develop-
ment. The purposes of these assessments in general
are described in the preceding paper (Roche, this
issue). For the child with kidney disease, the num-
ber of variables affecting growth make it difficult to
project adult stature. When a specific variable is
dominant, data is accumulating that make this pro-
jection possible. Elsewhere (Potter and Greifer;
Travis et al, this issue) is summarized experience in
children with various types of renal insufficiency
and in children after renal transplantation. Growth
rate can be improved but not sufficiently so that
stature and development are normal. By contrast,
children with uncomplicated renal tubular acidosis
(RTA) when treated adequately from an early age
may exhibit catch-up growth and attain normal stat-
ure (McSherry, this issue).
Growth assessment in the individual child with
kidney disease is helpful to physician and patient in
understanding the course of his disease, the effect
of therapy, and in gaining some projection of growth
potential. Serial growth assessment of a group of
children is helpful toward defining the variables of
disease most affecting growth. From such data the
natural history of disease can be defined in relation
to its effect upon ultimate stature and development.
Response of growth to therapy to evaluate the po-
tential efficacy of therapy is a third reason for as-
sessing growth.
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Stature is the index of growth of most concern to
children. How tall they are, how fast they are grow-
ing, and how tall they are going to be are the impor-
tant questions. Measuring stature serially is the first
requisite. Nutritional status, skeletal maturation,
and sexual development, however, all influence
statural growth and remaining growth potential.
These variables also are important in themselves in
evaluating the course of the disease and in planning
therapy.
Judging from past experience, there is a need to
develop guidelines for presenting data on growth as-
sessment of children with kidney disease, The rec-
ommendations in this report are presented as a step
towards fulfilling that need. Drawing from the pre-
vious paper (Roche, this issue), we recommend the
following measurements to be made at intervals
suitable for the purposes of the investigator. Some
recommendations about frequency of measure-
ment, method of recording, and data reduction for
individual and statistical treatment are also includ-
ed. The Combined Report on regular dialysis and
transplantation of children in Europe [1] is a useful
additional reference.
Measurements recommended
I) Chronological age. This is expressed in years
and decimals to the nearest hundredth.
2) Stattire. Recommended up to 2 yr, and if a
child is unable to assume the standing pose, it is
preferable to measure recumbent length. It should
always be stated clearly whether stature or recum-
bent length has been measured. The stature of a
child should preferably be measured using an ap-
paratus in which a counter-weighted headboard
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moves in the correct plane, e.g., Harpenden sta-
diometer. Stature should be measured at least twice
yearly and more often where more frequent evalua-
tion is useful, e.g., in evaluating a particular thera-
py. Height at birthday and at the beginning of each
calendar year are used by some. To improve the
projection of the final stature of a patient [2, 31, it is
suggested to measure the stature of both parents as
well.
3) Body weight. Weight should be measured in
the fasting or postabsorptive state, or at a standard
time of day. In dialyzed patients, weight should be
measured immediately after the dialysis session.
Except for the first month after start of dialysis,
mean values of several postdialysis weights should
be reported. For both measurements of stature and
weight, only very light clothing should be worn.
4) Skinfold thickness. Skinfold thickness should
be measured at the triceps and subscapular sites bi-
laterally using calibrated calipers. At the triceps
site, skinfold thickness should be taken at the level
of the midpoint between marks plotted over the left
acromion and olecranon in the midline of the poste-
rior aspect of the arm, when this is hanging relaxed.
The subscapular site is just inferior to the angle of
the scapula. The site of measurements and the pres-
ence of any anatomical abnormalities, such as an
arteriovenous shunt or fistula, which might influ-
ence the value obtained, should be clearly in-
dicated. The measurement can be used to estimate
body fat [4, 51.
5) Upper arm circumference. Upper arm circum-
ference is measured bilaterally to obtain an index of
muscle mass. The measurement is made to the near-
est millimeter at the same level as for the measure-
ment of the triceps skinfold thickness using a tape
that does not stretch. The expanded end tape is rec-
ommended (see Roche, this issue). The arm circum-
ference plus the triceps skinfold thickness can be
used to calculate the cross-sectional area of fat and
of muscle plus bone [4, 5].
6) Head circumference. Head circumference is
measured up to the age of 3 yr with the tape men-
tioned under no. 5. Children with kidney disease
characteristically have normal head growth.
7) Radiography. Radiographs should be taken
at 6-month intervals to obtain data about skeletal
maturity and skeletal status including osteodys-
trophy. These radiographs should be on left hand-
wrist and left knee.
a) Skeletal maturit. Skeletal maturity assess-
ments are needed because of the relationship of
skeletal maturation to other aspects of development
and to a child's potential for growth in stature. Re-
cently published methods for the assessment of the
hand-wrist [6, 7] and the knee [81 are recommended
rather than the Greulich-Pyle Atlas [9] for the hand-
wrist. The method used should be recorded. These
assessments should be made by an independent ob-
server to reduce bias and errors: consultations or
special arrangements can be made with those who
developed these assessments.
b) Skeletal status. Radiographs should be
screened for rickets, signs of secondary hyper-
parathyroidism (e.g., subperiosteal resorption) and
osteosclerosis. The amount of bone mineral present
should be estimated from the measured thickness of
the cortex of the second metacarpal or other bones
and/or by absorptiometry. In the future, comput-
erized tomography may be used to estimate bone
mineral.
8) Pubertal stage. The stage of puberty should be
determined in children according to Tanner's
grades [101, and testicular size should be graded or
measured [11, 121. The date of menarche should be
recorded as accurately as possible from frequent in-
quiry during the appropriate age range. This date
should be transformed to an age expressed in deci-
mals.
Frequency of,neasurement
All measurements should be taken at intervals of
6 months from the first observation of a child with a
progressive kidney disorder when stature is more
than 2 SD below the mean for age or when growth
velocity during a year is below the 5th percentile. In
end-stage renal disease patients, the measurements
should be obtained at the time of the first dialysis or
immediately before transplantation, respectively,
and at 6-month intervals thereafter, as well as at
each change of the mode of treatment (peritoneal or
hemodialysis, hospital or home dialysis, at each
transplantation, etc.). The European Dialysis and
Transplant Association proposed additional mea-
surements at the end of each calendar year [1].
In children with renal insufficiency and in chil-
dren after transplantation, the data on growth and
development should be supplemented by con-
comitant measurements of kidney function and of
nutritional status [13]. In dialyzed patients, the fre-
quency and duration as well as other clinical details
of the dialysis procedure should be noted. In pa-
tients receiving steroid therapy, the total dose of
corticosteroid given per month should be recorded.
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The methods used should be described, and data
obtained should be entered on flow sheets and
graphs systematically for easy data retrieval.
Utilization of data from an individual child
Sequential data on stature and weight, recorded
as discussed above, should be plotted on appropri-
ate charts against chronologic age and kept in the
patient's record. This documents the child's prog-
ress in relation to his peers, which is important in-
formation to the child, and allows the relation of
weight to stature to be examined. The child's stat-
ure in relation to parental stature can also be as-
sessed using appropriate charts (see Roche, this is-
sue). Sequential measurements of stature should be
plotted against estimates of skeletal maturity re-
corded as bone age or maturity scores 6—8I. Stan-
dard stature for age charts can be used for this pur-
pose substituting bone age for chronological age.
The mean bone age and chronological age will cor-
respond, but the percentiles or standard deviations
for stature around the mean will not necessarily be
the same for bone age as for chronologic age. This
plot is particularly important in evaluating growth
potential because of the relationship between
growth potential and skeletal maturation and the
frequency of retardation of skeletal maturation in
children with chronic renal failure.
Increments in stature over a 1-yr period can also
be plotted against the age of the child (growth veloc-
ity) l4]. When the increments in stature are related
to an interval in skeletal maturation and plotted
against the bone age rather than chronologic age,
the data can be evaluated more accurately in terms
of the growth potential of the child. Errors inher-
ent in determining growth velocity in this way
are a composite of the error of the stature in-
crements (small) and the assessment of bone age
(larger), and consequently the sum of errors is
larger than the error involved in the construction of
the conventional growth velocity chart which re-
lated increments in stature to chronologic age.
Therefore, the interval between assessment should
be sufficient to minimize the error of measurement
of bone age. Estimates of growth velocity are vari-
able from period to period in an individual child (see
Roche, this issue). The technique of curve-fitting
described by Roche promises to improve the useful-
ness of this method. Growth velocity charts are also
useful in judging differences between groups of chil-
dren, and this is discussed below.
Growth rate in the first two years of life is very
rapid, so that growth-retarding influences in this pe-
nod are particularly serious [15]. Growth velocity
(in centimeters per year) from 3 yr of age to puberty
is relatively constant, as is the standard deviation of
growth velocity for that period. With the onset of
puberty and the pubertal growth spurt, variability
again makes it difficult to evaluate change. Com-
paring growth velocity with skeletal maturity and
sexual maturation removes some of the variability.
Growth retardation associated with comparable re-
tardation of skeletal maturity has less effect on
growth potential than growth retardation when skel-
etal maturation proceeds. These factors are impor-
tant considerations in evaluating growth of the indi-
vidual child or growth data from a group of chil-
dren.
Utilization of data from group data: Single variable
Group data are used to define the natural history
of a disease upon growth including the impact of
specific complications or therapies. Describing the
natural history of a congenital disease upon growth
has the advantage in that the disease is present at
birth.
Data from children with congenital disease and
growth retardation by 3 yr of age can be expressed
as standard deviation scores, and the average of
these scores can be used to express the magnitude
of growth impairment for the group. Where the data
are cross sectional, each child should be entered
only once. The standard deviation scores can be
treated statistically as any set of numbers.
The more conventional method for expressing
data from a group is the presentation of individual
data on a standard growth chart or growth velocity
chart that conveys a visual impression of growth
performance. Growth performance of individuals in
the group can be expressed over a period of time by
this method, but it is not suitable for statistical
treatment. Growth or growth velocity for a group
can also be expressed in relation to bone age to in-
dicate qualitatively the remaining growth potential.
Data expressed by this method, however, cannot be
treated statistically.
When two groups of children are to be compared
in terms of growth impairment, the age and skeletal
maturity scores should be between ages 3 and II.
For this interval, it is ideal to treat boys and girls
separately, but if like numbers are in each group
and the individuals are prepubertal, they may be
combined. The simplest method for comparing two
groups with statistical methods is the expression of
stature as standard deviation score. Each child
should appear only once in a group. When stature is
Growth assessment in renal insufficiency 381
expressed as a standard deviation score, with bone
age rather than chronologic age as the reference, it
should be noted that the standard deviation for the
normal population refers to chronologic age and
some error is introduced. This error, however, may
not be large especially when comparing groups of
children. Data providing standard deviations of
stature versus bone age for normal children would
be very useful in eliminating this error.
When the effect of therapy is being evaluated, the
comparison may be between a control and test
group for a period time, or between a control and
treatment period in the same patients. The se-
quence in the serial study should be random. In ei-
ther case, the period of observation need be only as
long as that required either to show no effect in a
period when a response can be expected (negative
result) or long enough for therapy to change stature
when compared with controls (positive result). Sea-
sonal effects can be ignored when entry into study is
random with respect to time, and seasonal effects
are therefore randomly distributed. When the result
is positive, it usually will be necessary to conduct a
second study of longer duration and to compare the
effect of therapy upon skeletal maturity as well as
growth velocity.
Using standard deviation scores is preferred to
expressing growth as centimeters per year or as
100% normal, because "normal" growth velocity
for growth-retarded children is not known. Stan-
dard deviation scores of stature also are preferred
to expressing growth velocity in relation to standard
deviation of normal growth velocity although for
purposes of comparing growth velocity between
two groups, this method may be useful.
When growth velocity of two groups of children
are expressed in relation to a change in bone age,
the data are less precise because there is a relatively
large inaccuracy in assessing bone age.
When comparisons of weight are made, the data
may be expressed in relation to height graphically,
or they may be expressed as a percent of weight
appropriate for height [16]. When expressed in this
latter mode, statistical comparison is possible. Er-
rors of interpretation of weight occur when edema
is present (see Holliday and Chantler, this issue).
When skinfold thickness and arm circumference
measurements are compared between groups or se-
rially in the same group, it is possible to test for
significance of difference. When two groups are
being compared, however, it is important that they
have the same age and sex distribution; and when
serial increments are obtained, it is desirable that
the control and test periods be randomly assigned
first place in the sequence.
Summary
The serial measurement of stature, weight, skin-
fold thickness, mean arm circumference, skeletal
maturity, and where appropriate, stage of sexual
development are recommended as suitable indices
for assessing growth in children with kidney dis-
ease. Methods of expressing the data for evaluating
the individual child are generally used methods.
Emphasis is given to relating stature to bone age in
evaluating growth potential. Methods for com-
paring growth rates in groups of children are less
well-developed. Using standard deviation scores is
recommended for comparing stature in two groups
of children or in the same child observed at the end
of two different regimens. Weight using ideal
weight-for-height as reference from a group of chil-
dren can be treated statistically. Data of skinfold
thickness and arm circumference from two groups
can be handled statistically only when the groups
are comparable in age and sex.
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